PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
agilon health, inc. (AGL)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS00857U1079
CUSIP00857U107
SectorHealthcare
IndustryMedical Care Facilities

Highlights

Market Cap$2.00B
EPS-$0.48
Revenue (TTM)$4.32B
Gross Profit (TTM)$112.29M
EBITDA (TTM)-$216.09M
Year Range$4.88 - $28.99
Target Price$8.11
Short %40.50%
Short Ratio8.46

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AGL

agilon health, inc.

Popular comparisons: AGL vs. QQQ, AGL vs. COST

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in agilon health, inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%OctoberNovemberDecember2024FebruaryMarch
-81.52%
25.85%
AGL (agilon health, inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

agilon health, inc. had a return of -54.34% year-to-date (YTD) and -78.95% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-54.34%10.04%
1 month-7.13%3.53%
6 months-68.84%22.79%
1 year-78.95%32.16%
5 years (annualized)N/A13.15%
10 years (annualized)N/A10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-53.07%4.07%
2023-7.47%0.23%1.35%-41.00%18.17%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for agilon health, inc. (AGL) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
AGL
agilon health, inc.
-1.19
^GSPC
S&P 500
2.76

Sharpe Ratio

The current agilon health, inc. Sharpe ratio is -1.19. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-1.19
2.76
AGL (agilon health, inc.)
Benchmark (^GSPC)

Dividends

Dividend History


agilon health, inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-86.75%
0
AGL (agilon health, inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the agilon health, inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the agilon health, inc. was 88.99%, occurring on Mar 25, 2024. The portfolio has not yet recovered.

The current agilon health, inc. drawdown is 86.75%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-88.99%Jun 21, 2021695Mar 25, 2024
-12.99%May 10, 20214May 13, 20216May 21, 202110
-9.56%Jun 2, 20214Jun 7, 20216Jun 15, 202110
-5.62%Apr 21, 20212Apr 22, 20219May 5, 202111
-3.23%Apr 16, 20211Apr 16, 20211Apr 19, 20212

Volatility

Volatility Chart

The current agilon health, inc. volatility is 21.89%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%OctoberNovemberDecember2024FebruaryMarch
21.89%
2.82%
AGL (agilon health, inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of agilon health, inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items